Healthcare | September 23, 2022
KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke
Results consistent with previous trials, reinforcing benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in previously treated patients
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
Subscribe To Our Newsletter & Stay Updated
